Skip Navigation

Cardiovascular Research 2002 54(2):270-279; doi:10.1016/S0008-6363(01)00557-0
© 2002 by European Society of Cardiology
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by van der Velden, H. M.W
Right arrow Articles by Jongsma, H. J
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by van der Velden, H. M.W
Right arrow Articles by Jongsma, H. J
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 2002, European Society of Cardiology

Cardiac gap junctions and connexins: their role in atrial fibrillation and potential as therapeutic targets

Huub M.W van der Velden* and Habo J Jongsma

Department of Medical Physiology, University Medical Centre Utrecht, Universiteitsweg 100, P.O. Box 85060, 3508 AB Utrecht, The Netherlands

* Corresponding author. Tel.: +31-30-253-8900; fax: +31-30-253-9036 velden{at}med.uu.nl

In the heart, changes in velocity and in patterns of conduction of myocardial electrical activity can affect cardiac rhythm and the coordination of contraction. Abnormal electrical coupling between cardiomyocytes through gap junctions is, therefore, considered an important factor in various pathophysiologic conditions. In the present report we summarize the literature on gap junctions and their structural proteins, the connexins, in the normal and fibrillating atrium. Putative implications of the recently reported remodelling of atrial gap junctions for stability of the arrhythmia will be discussed. Also the reversibility of the remodelling process will be addressed in the light of a potentially new therapeutic target for controlling the progression of atrial fibrillation (AF).

KEYWORDS Arrhythmia (mechanisms); Gap junctions; Remodeling; Supraventr. arrhythmia


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Cardiovasc ResHome page
H. Zhang, C. J. Garratt, J. Zhu, and A. V. Holden
Role of up-regulation of IK1 in action potential shortening associated with atrial fibrillation in humans
Cardiovasc Res, June 1, 2005; 66(3): 493 - 502.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
S. Dhein and H. J Jongsma
Forming the network--gap junctions in the cardiovascular system
Cardiovasc Res, May 1, 2004; 62(2): 225 - 227.
[Full Text] [PDF]

Home page
 Cardiovasc ResHome page
N. J. Severs, S. R. Coppen, E. Dupont, H.-I Yeh, Y.-S. Ko, and T. Matsushita
Gap junction alterations in human cardiac disease
Cardiovasc Res, May 1, 2004; 62(2): 368 - 377.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
P. E.M. Martin and W.H. Evans
Incorporation of connexins into plasma membranes and gap junctions
Cardiovasc Res, May 1, 2004; 62(2): 378 - 387.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
S. Nattel, M. Allessie, and M. Haissaguerre
Spotlight on atrial fibrillation--the 'complete arrhythmia'
Cardiovasc Res, May 1, 2002; 54(2): 197 - 203.
[Full Text] [PDF]


Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.